-
1 Comment
Shandong Weigao Group Medical Polymer Company Limited is currently in a long term uptrend where the price is trading 7.2% above its 200 day moving average.
From a valuation standpoint, the stock is 95.5% cheaper than other stocks from the Healthcare sector with a price to sales ratio of 5.1.
Shandong Weigao Group Medical Polymer Company Limited's total revenue rose by 15.4% to $6B since the same quarter in the previous year.
Its net income has increased by 16.8% to $1B since the same quarter in the previous year.
Finally, its free cash flow fell by 14.4% to $518M since the same quarter in the previous year.
Based on the above factors, Shandong Weigao Group Medical Polymer Company Limited gets an overall score of 4/5.
| Exchange | HK |
|---|---|
| ISIN | CNE100000171 |
| CurrencyCode | HKD |
| Sector | Healthcare |
| Industry | Medical Instruments & Supplies |
| Beta | 0.59 |
|---|---|
| Market Cap | 26B |
| PE Ratio | 12.34 |
| Target Price | 6.5889 |
| Dividend Yield | 4.6% |
Shandong Weigao Group Medical Polymer Company Limited engages in the research and development, production, wholesale, and sale of medical devices in the People's Republic of China. It operates through Medical Device Products, Orthopaedic Products, Interventional Products, Pharma Packaging Products, Blood Management Products, and Others segments. The company offers single use medical consumables and materials, including infusion sets, syringes, blood bags and blood component segregators consumable, blood sampling products, prefilled syringes for pre-pack medication and medical needles which mainly include intravenous needles, syringe needles, intravenous catheter needles, blood sampling needles and irregular needles; orthopedic materials and instruments, including trauma products of steel plates and screws, spinal implants, and artificial joints; and blood purification consumables and equipment, including puncture needles, extracorporeal blood circuit for blood purification sets, dialyzers and related consumables. It also provides tumour and blood vessel interventional instruments; flushing syringes; blood collection, irradiation, storage, separation and sterilization products; implantation materials and artificial organs; medical PVC granules, plastic packing bags, and carton boxes; medical polymer materials and products; injection puncture Instruments; medicines; and X-ray based irradiation machines. In addition, it is involved in the finance leasing and factoring business; provision of enterprise management advisory services, logistics and storage, and computer technical services; and sale of electronic products. The company was incorporated in 2000 and is based in Weihai, the People's Republic of China.
Learn MoreHere's how to backtest a trading strategy or backtest a portfolio for 1066.HK using our backtest tool. PyInvesting provides the backtesting software for you to backtest your investment strategy. Our backtest software is written using Python code and allows you to backtest stock, backtest etf, backtest options, backtest crypto and backtest forex online. Our backtesting Python framework is highly robust and gives you a realistic simulation of how your strategy would have performed in the past using backtest data.
© PyInvesting 2025
